BCR-ABL, ETV6-RUNX1 and E2A-PBX1: Prevalence of the most common acute lymphoblastic leukemia fusion genes in Mexican patients

Leukemia Research

Volumn 32, Issue 10, 2008, Pages 1518-1522

  Jimenez Morales S ^a,b   Miranda Peralta, E ^c   Saldana Alvarez Y ^a   Perez Vera, P ^d   Paredes Aguilera, R ^d   Rivera Luna, R ^d   Velazquez Cruz R ^a   Ramirez Bello J ^a   Carnevale, A ^e   Orozco, L ^a,f  

^a INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^c HOSPITAL GENERAL DE MÉXICO   (Mexico)

^d INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^e CENTRO MÉDICO NACIONAL 20 DE NOVIEMBRE   (Mexico)

^f Genomic Science Program   (Mexico)

Author keywords

Acute lymphoblastic leukemia (ALL); BCR ABL; E2A PBX1 fusion genes; ETV6 RUNX1; Mexican pediatric patients

Indexed keywords

BCR ABL PROTEIN; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR PBX1; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CANCER RELAPSE; CHILD; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; FUSION GENE; GENE EXPRESSION; GENE FREQUENCY; HUMAN; IMMUNOPHENOTYPING; INFANT; MAJOR CLINICAL STUDY; MALE; MEXICO; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CORE BINDING FACTOR ALPHA 2 SUBUNIT; FEMALE; FUSION PROTEINS, BCR-ABL; GENE FREQUENCY; HOMEODOMAIN PROTEINS; HUMANS; INFANT; MALE; MEXICO; ONCOGENE PROTEINS, FUSION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS;

EID: 44749088149     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.03.021     Document Type: Article

References (48)

1. Fajardo-Gutiérrez A., Juárez-Ocaña S., González-Miranda G., Palma- Padilla V., Carreón-Cruz R., Ortega-Alvárez M.C., and Mejía-Arangure J.M. Incidence of cancer in children residing in ten jurisdictions of the Mexican Republic: importance of the cancer registry (a population-based study). BMC Cancer 197 (2007) 68-72
2. Rubnitz J.E., and Look A.T. Molecular genetics of childhood leukemias. J Pediatr Hematol Oncol 20 (1998) 1-11
3. Crist W.M., Carroll A.J., Shuster J.J., Behm F.G., Whitehead M., and Vietti T.J. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group Study. Blood 76 (1990) 117-122
4. Crist W., Carroll A., Shuster J., Jackson J., Head D., Borowitz M., et al. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood 76 (1990) 489-494
5. Rubnitz J.E., Downing J.R., Pui C.H., Shurtleff S.A., Raimondi S.C., Evans W.E., et al. Tel gene rearrangement in acute lymphoblastic leukemia: a new genetics marker with prognostic significance. J Clin Oncol 15 (1997) 1150-1157
6. Pui C.H., Sandlund J.T., Pei D., Rivera G.K., Howard S.C., Ribeiro R.C., et al. Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA 290 (2003) 2001-2007
7. Meyer-Monard S., Parlier V., Passweg J., Mühlematter D., Hess U., Bargetzi M., et al. Combination of broad molecular screening and cytogenetic analysis for genetic risk assignment and diagnosis in patients with acute leukemia. Leukemia 20 (2006) 247-253
8. Schultz K.R., Pullen D.J., Sather H.N., Shuster J.J., Devidas M., Borowitz M.J., et al. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood 109 (2007) 926-935
9. Hughes T.P., Kaeda J., Branford S., Rudzki Z., Hochhaus A., Hensley M.L., et al. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. N Engl J Med 349 (2003) 1423-1432
10. Stams W.A., den Boer M.L., Beverloo H.B., Kazemier K.M., van Wering E.R., Janka-Schaub G.E., and Pieters R. Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia. Haematologica 90 (2005) 1697-1699
11. Casagrande G., te Kronnie G., and Basso G. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line. Haematologica 9 (2006) 765-771
12. Rubnitz J.E., Behm F.G., Wichlan D., Ryan C., Sandlund J.T., Ribeiro R.C., et al. Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup. Leukemia 13 (1999) 19-21
13. Shurtleff S.A., Bujis A., Behm F.G., Rubnitz J.E., Raimondi S.C., Hancock M.L., et al. Tel/AML1 fusion resulting from a cryptic t(12;21) in the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9 (1995) 1985-1989
14. Ramakers-van Woerden N.L., Pieters R., Loonen A.H., Hubeek I., van Drunen E., Berna B.H., et al. TEL/AML1 gene fusion is related to in vitro drug sensitivity for l-asparaginase in childhood acute lymphoblastic leukemia. Blood 96 (2000) 1094-1099
15. García-Sanz R., Alaejos I., Orfão A., Rasillo A., Chillón M.C., Tabernero M.D., et al. Low frequency of the TEL/AML1 fusion gene in acute lymphoblastic leukaemia in Spain. Br J Haematol 107 (1999) 667-669
16. Codrington R., O'Connor H.E., Jalali G.R., Carrara P., Papaioannou M., Hart S.M., et al. Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value. Br J Haematol 111 (2000) 1071-1079
17. Izraeli S., Janssen J.W.G., Haas A.O., Harbott J., Brok-Simoni F., Walther J.U., Kovar H., Henn R., Ludwing W.D., Reitera P., Rechavi G., Bartram C.R., Gadner H., and Lion T. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses. Leukemia 7 (1993) 671-678
18. Raimondi S.C., Behm F.G., Roberson P.K., Williams D.L., Pui C.H., Crist W.M., et al. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J Clin Oncol (1990) 1380-1388
19. Schlieben S., Borkhardt A., Reinisch I., Ritterbach J., Janssen J.W., Ratei R., et al. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALLBFM-90 and CoALL-05-92. Leukemia 10 (1996) 957-963
20. Frost B.M., Forestier E., Gustafsson G., Nygren P., Hellebostad M., Jonmundsson G., et al. Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia. Leukemia 19 (2005) 165-169
21. Aldrich M.C., Zhang L., Wiemels J.L., Ma X., Loh M.L., Metayer C., et al. Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California. Cancer Epidemiol Biomarkers Prev 15 (2006) 578-581
22. Ariffin H., Chen S.P., Kwok C.S., Quah T.C., Lin H.P., and Yeoh A.E.J. Ethnic differences in the frequency of subtypes of childhood acute lymphoblastic leukemia: results of the Malaysia-Singapore Leukemia Study Group. Pediatr Hematol Oncol 29 (2007) 27-31
23. Kawasaki E.S., Clark S.S., Coyne M.Y., Smith S.D., Champlin R., Witte O.N., and McCormick F.P. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci 85 (1988) 5698-5702
24. Magalhâes I.Q., Pombo-de Oliveira M.S., Bennet C.A., Cordoba J.C., Dobbin J., Ford A.M., and Greaves M.F. TEL-AML1 fusion gene frequency in pediatric acute lymphoblastic leukaemia in Brazil. Br J Haematol 111 (2000) 204-207
25. Hunger S.P., Galili N., Carroll A.J., Crist W.M., Link M.P., and Cleary M.L. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood 77 (1991) 687-693
26. Pérez-Vera P., Mújica-Sánchez M., Carnevale A., Rivera-Luna R., Paredes R., Martínez A., and Frías S. Cytogenetics in acute lymphoblastic leukemia in Mexican children: an institutional experience. Arch Med Res 32 (2001) 202-207
27. Devaraj P.E., Foroni L., Kitra-Roussos V., and Secker-Walker L.M. Detection of BCR-ABL and E2A-PBX1 fusion genes by RT-PCR in acute lymphoblastic leukaemia with failed or normal cytogenetics. Br J Haematol 89 (1995) 349-355
28. Griffin T.C., Tomlinson G.E., Raimondi S.C., Sandoval C., Timmons C.F., Rosenfield C., et al. Childhood acute lymphoblastic leukemia with both t(1;19) and t(9;22). Leukemia 6 (1992) 535-540
29. Wiemels J.L., Leonard B.C., Wang Y., Segal M.R., Hunger S.P., Smith M.T., et al. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukaemia. Proc Natl Acad Sci USA 99 (2002) 15101-15106
30. Tchirkov A., Bons J.M., Chassagne J., Schoepfer C., Kanold J., Briançon G., et al. Molecular detection of a late-appearing BCR-ABL gene in a child with T cell acute lymphoblastic leukemia. Ann Hematol 77 (1998) 55-59
31. Kim M., Lim J., Kim Y., Han K., Kang C.S., Kim H.J., and Min W.S. A case of therapyrelated acute myeloid leukemia associated with inv(16), with subsequent development of t(9;22). Leukemia 20 (2006) 746-752
32. Trka J., Zuna J., Hrusák O., Kalinová M., Muzíková K., Lauschman H., and Starý J. Impact of TEL/AML1-positive patients on age distribution of childhood acute lymphoblastic leukemia in Czech Republic. Pediatric Hematology Working Group in Czech Republic. Leukemia 12 (1998) 996-997
33. Pérez-Vera P., Montero-Ruiz O., Frías S., Ulloa-Avilés V., Cárdenas-Cardós R., Paredes-Aguilera R., et al. Detection of ETV6 and RUNX1 gene rearrangements using fluorescence in situ hybridization in Mexican patients with acute lymphoblastic leukemia: experience at a single institution. Cancer Genet Cytogenet 162 (2005) 140-145
34. Martínez-Ramírez A., Urioste M., Contra T., Cantalejo A., Tavares A., Portero J.A., et al. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia. Haematologica 86 (2001) 1245-1253
35. Zen P.R., Lima M.C., Coser V.M., Silla L., Daudt L., Fernandes M.S., Neumann J., Mattevi M.S., Ortigara R., and Paskulin G.A. Prevalence of TEL/AML1 fusion gene in Brazilian pediatric patients with acute lymphoblastic leukemia. Cancer Genet Cytogenet 151 (2004) 68-72
36. Woo H.Y., Kim D.W., Park H., Seong K.W., Koo H.H., and Kim S.H. Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia. J Korean Med Sci 20 (2005) 36-41
37. Nakao M., Yokota S., Horiike S., Taniwaki M., Kashima K., Sonoda Y., et al. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Leukemia 10 (1996) 1463-1470
38. Artigas A.C.G., Cabrera C.M.E., Melo A.A., Páez F.E., Arriagada M.M., Astete A.C., et al. Frequency of TEL/AML1 and BCR/ABL fusion genes in children with acute lymphoblastic leukemia. Rev Med Chil 134 (2006) 1367-1376
39. Emerenciano M., Agudelo Arias D.P., Coser V.M., de Brito G.D., Macedo Silva M.L., et al. Molecular cytogenetic findings of acute leukemia included in the Brazilian Collaborative Study Group of infant acute leukemia. Pediatr Blood Cancer 47 (2006) 549-554
40. Salari K., Choudhry S., Tang H., Naqvi M., Lind D., Avila P.C., et al. Genetic admixture and asthma-related phenotypes in Mexican American and Puerto Rican asthmatics. Genet Epidemiol 29 (2005) 76-86
41. Anguita E., Gonzalez F.A., Contra T., Martin N., Valverde F., and Villegas A. Usefulness of molecular screening in childhood lymphoblastic leukemias. Sangre 43 (1998) 7-11
42. Elia L., Mancini M., Moleti L., Meloni G., Buffolino S., Krampera M., et al. A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. Haematologica 88 (2003) 275-279
43. Liang D.C., Shih L.Y., Yang C.P., Hung I.J., Chen S.H., Jaing T.H., et al. Multiplex RT-PCR assay for the detection of major fusion transcripts in Taiwanese children with B-lineage acute lymphoblastic leukemia. Med Pediatr Oncol (2002) 3912-3917
44. Marín C., Martínez-Delgado B., Meléndez B., Larrayoz M.J., Martínez-Ramírez A., Robledo M., et al. Multiplex-polymerase chain reaction assay for the detection of prognostically significant translocations in acute lymphoblastic leukemia. Haematologica 86 (2001) 254-260
45. Siraj A.K., Ozbek U., Sazawal S., Sirma S., Timson G., Al-Nasser A., et al. Preclinical validation of a monochrome real-time multiplex assay for translocations in childhood acute lymphoblastic leukemia. Clin Cancer Res 8 (2002) 3832-3840
46. Gaynon P.S., Crotty M.L., Sather H.N., Bostrom B.C., Nachman J.B., Steinherz P.G., et al. Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 fusion transcripts in newly diagnosed children with acute lymphoblastic leukemia: a Children's Cancer Group initiative. Leuk Lymphoma 26 (1997) 57-65
47. Nasedkina T., Domer P., Zharinov V., Hoberg J., Lysov Y., and Mirzabekov A. Identification of chromosomal translocations in leukemias by hybridization with oligonucleotide microarrays. Haematologica 87 (2002) 363-372
48. Hill A., Short M.A., Varghese C., Kusumakumary P., Kumari P., and Morgan G.J. The t(12:21) is underrepresented in childhood B-lineage acute lymphoblastic leukemia in Kerala, Southern India. Haematologica 90 (2005) 414-416